There is widespread recognition that atrial fibrillation (AF) may recur episodically or be present in a sustained fashion following a first-detected episode. Yet there exists a prevailing assumption that AF may occur as an isolated event without recurrence, particularly when an acute reversible, or secondary, precipitant is associated with the episode. Previous consensus guidelines stated that treatment of an underlying reversible precipitant may "terminate the arrhythmia without recurrence," 1 although, as acknowledged in more recent guidelines, data addressing the longterm follow-up of such patients are incomplete. 2 There is a need to understand the long-term clinical implications of AF that occurs in the context of secondary precipitants. The distinction as to whether AF is likely to recur after a particular precipitant has important clinical implications, since it may affect whether or not AF is regarded as a chronic condition, and thus whether risks of heart failure, stroke, and increased mortality typically attributed to AF are applicable to a specific patient. Perceptions about the likelihood of AF recurrence may influence how closely patients are monitored for recurrence, and whether general principles of AF management, such as thromboembolism prophylaxis, are recommended. Therefore, we sought to determine if the long-term risks of both AF recurrence and morbidity differ according to the presence or absence of potential secondary AF precipitants in community-dwelling individuals from the Framingham Heart Study.
Methods

Participants
Participants from the Framingham Heart Study Original 3 and Offspring 4 cohorts with firstdetected AF between 1949 and 2012 were eligible for this study (n=1782). We excluded individuals who died within 30 days of first-detected AF (n=215) in keeping with prior particular precipitant has important clinical implications, since it may affect whe et th ther er e o o or r r no no not t t AF A AF is egarded as a chronic condition, and thus whether risks of heart failure, stroke, and increased mo mort rt rtal al alit it ity y ty ty typi pi pica all ll ly y y at a tributed to AF are applicab ble le le t to o a specific pat at tie i nt t. P Pe Perceptions about the i i ike ke eli lihood of AF AF F rec ecur ur rre e enc nc nce e e ma ma m y y in in infl fl f u ue en n nce h ho how w c cl lo os sely y y pa pati ti t e en nts ts ar r re m mo on onit itor or red ed ed f for or r r rec ec e u u urre re renc nc ce, e, an nd d d wh wh whet ethe he er r r ge gen ne er ra ral l p pr prin in nci cipl l le es e of of of A A AF F ma ma mana na nage ge g me me m n n nt, , su su uch ch h a a as s s th h hro ro r mb mb mboe oe o mb mb mbol olis is sm m m pr pr p op op ophy hyl l lax xi xis, s, a are re e ecommende ed. d. d. Th Th her er eref ef for or o e, e, w w we e e so so soug ug u ht ht h t t to o o de de dete te term rm rmin in ne e e if if f t the he e l lon on ong-g-g te te term rm rm r r ris is sks ks ks o o of f f bo bo oth th th A A AF F F re re r currence by guest on April 20, 2017 http://circ.ahajournals.org/ Downloaded from analyses, 5, 6 as we felt that events occurring during this interval might plausibly be related to the index AF event and because our aim was to assess the relations between the presence or absence of secondary AF precipitants and long-term clinical outcomes. We also excluded individuals with incomplete baseline covariate data (n=158). A total of 1409 individuals remained eligible for analysis. The Boston University Medical Center Institutional Review Board approved the study protocols, and all participants signed consent forms at each examination cycle.
Assessment of first-detected AF
At each Framingham Heart Study clinic examination (about every two years for the Original cohort and every four to eight years for the Offspring cohort), participants' medical histories, physical examinations, and electrocardiograms were obtained to assess symptoms and findings suggestive of cardiovascular disease. Records of all interim outpatient appointments and hospitalizations for cardiovascular disease were sought for manual review by mailings and telephone calls via health history updates every 24 months. Participants were classified as having AF if the arrhythmia was present on an electrocardiogram obtained at a Framingham Heart Study clinic visit or encounter with an external clinician, Holter monitoring, or noted in hospital records as previously described. 7, 8 Study investigators reviewed all available records, regardless of symptoms, to determine the dates of AF. During ascertainment of each first-detected AF episode, clinical records were reviewed and a standardized form was completed to capture potential precipitants of the firstdetected episode. Two physicians adjudicated first-detected AF events and precipitants, and at least one cardiologist adjudicated subsequent encounters (see below).
Definition of secondary AF
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College of Cardiology / Heart Rhythm Society guidelines. 1,2 Secondary precipitants included surgery (within 30 days, which we subdivided into cardiothoracic and non-cardiothoracic), acute myocardial infarction (within 30 days), acute infection (including but not restricted to sepsis, non-pulmonary infections, pneumonia, bronchitis, and chronic obstructive lung disease exacerbation), acute alcohol consumption, thyrotoxicosis, acute pericardial disease (pericarditis or tamponade), acute pulmonary embolism, and other acute pulmonary pathology (e.g., pneumothorax and bronchoscopy-related). If individuals had more than one precipitant, we designated a main precipitant in a hierarchical fashion using the following sequence:
cardiothoracic surgery, non-cardiothoracic surgery, acute myocardial infarction, acute infection, and other precipitants.
Ascertainment of covariates, recurrent AF, heart failure, stroke, and death
Baseline characteristics were ascertained from study examinations, with the exception of AF precipitant, age, and medical therapy associated with the first-detected episode. We included characteristics from the closest examination within 10 years prior to first-detected AF (median hospitalization, the first episode of AF, the first episode of sinus rhythm, and the final cardiac rhythm were recorded. We classified cardioversion attempts as unsuccessful when AF was noted cardiothoracic surgery, non-cardiothoracic surgery, acute myocardial infarction, , a a acu u ute te i i inf nf nfec ec ecti ti tion o , , and other precipitants.
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Further details regarding data ascertainment are in the supplement. Participants in our analysis were followed through 2012, to their last examination, health history update, or death.
Derivation of clinical outcome risk pools
Since we excluded individuals with an outcome condition present at AF onset, the number of individuals at risk for each clinical outcome varied (AF recurrence, heart failure, stroke, and mortality; Supplemental Figure) . For analyses of recurrent AF we omitted individuals in a hierarchical fashion as follows: those with sustained (permanent) AF (n=396) because they were not at risk for AF recurrence (defined as AF without any intercurrent sinus rhythm or successful cardioversion following first-detected AF); those with only one electrocardiogram (n=88) and less than 30 days between the first and last electrocardiogram (n=45) in whom we were unable to assess for long-term AF recurrence; and those who died or were last contacted within 30 days of sinus rhythm after initial AF (n=34) to ensure that restoration of sinus rhythm and a potential subsequent recurrence of AF were not associated with a terminal illness. For analyses of incident heart failure and stroke, we omitted individuals with a history of the respective conditions at or within 30 days of first-detected AF (n=302 for heart failure and n=147 for stroke).
Statistical analysis
After first-detected AF, we estimated the cumulative incidence of AF recurrence, heart failure, stroke, or death using the Kaplan-Meier method. AF recurrence was defined as the first recurrent AF episode. We adjusted for the competing risk of death for analyses of AF recurrence, heart mortality; Supplemental Figure) . For analyses of recurrent AF we omitted indiv iv vid idua u u ls ls ls i i in n n a a a hierarchical fashion as follows: those with sustained (permanent) AF (n=396) because they were no ot t at at at r r ri is isk k k fo fo for r r AF AF F r r rec e urrence (defined as AF wit th ho hou u ut any intercurr rr re e f f nt s sin in inu u us rhythm or successful failure, and stroke. 10 We stratified estimates by the presence or absence of secondary AF precipitants. For analyses of heart failure, stroke, and death, person-time began 30 days after first-detected AF. For analyses of AF recurrence, person-time began 30 days after the first documented sinus rhythm (including successful cardioversion) following first-detected AF, and ended at the first recurrent AF episode. Follow-up was censored at last contact for all analyses, as well as at death for analyses of AF recurrence, heart failure, and stroke. We assessed the multivariable-adjusted relations between secondary AF and each outcome using proportional hazards regression from which we report the hazard ratio (HR) and 95% confidence interval (CI). We adjusted for covariates associated with AF, including age, sex, height, weight, systolic and diastolic blood pressure, treatment with antihypertensive medication, current smoking, diabetes, prior myocardial infarction, prior heart failure, and valvular heart disease. 11, 12 To account for potential secular differences in AF detection, comorbidities, and treatments, we also adjusted for calendar year of AF detection and Framingham cohort (Original or Offspring). In additional models, we adjusted for baseline cardioversions (occurring prior to the beginning of person-time), and antiarrhythmic drug therapy during follow-up as a time-varying covariate. In analyses of stroke and mortality, we also adjusted for antiplatelet and anticoagulant use as timevarying covariates. Proportional hazards assumptions were verified with multiplicative interaction terms between covariates and the natural logarithm of follow-up time.
In addition, we estimated the cumulative incidence of recurrent AF according to the secondary AF precipitant categories outlined above. We compared cumulative incidences of recurrent AF across categories using Gray's test, 13 and examined multivariable adjusted relations using proportional hazards regression with cardiothoracic surgery as the referent precipitant.
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Secondary analyses
In secondary analyses we explored the associations between various factors and recurrent AF among participants with secondary precipitants using multivariable proportional hazards regression. In sensitivity analyses, we included individuals with atrial flutter (n=121; see supplement for ascertainment details).
For all analyses, the a priori significance threshold was P<0.05 using two-sided tests.
Analyses were conducted using SAS version 9.3 for Windows (SAS institute, Cary, NC).
Results
Among the 1409 participants with first-detected AF eligible for analysis, the mean (± standard deviation) age was 74 ± 11 years, 681 (48%) were women, and 439 (31%) had at least one secondary AF precipitant ( Table 1) . Among participants with a secondary precipitant, 294 (67%)
had one, and 125 (28%) had at least two precipitants (Supplemental Table 1 Among the 846 individuals without permanent AF who were eligible for analyses of AF recurrence, 325 (38%) had a first-detected AF episode attributed to a secondary precipitant.
Recurrent AF occurred in 544 individuals. The 5-, 10-, and 15-year cumulative incidences of recurrent AF were 42%, 56% and 62% among participants with a secondary AF precipitant, in
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During follow-up, incident heart failure occurred in 294 (27%) of 1107 individuals at risk, incident strokes in 209 (17%) of 1262 at risk, and 1098 (78%) of 1409 participants included in the analysis died ( Table 2) . Approximately one-third of individuals in each of the risk pools for heart failure, stroke, and mortality had a secondary AF precipitant. The cumulative incidences of heart failure, stroke, and death are displayed in Figure 2 . In multivariable models adjusted for clinical risk factors, cardioversions, and antiarrhythmic drug use, we observed a ecurrence analyses into the following categories: cardiothoracic surgery (n=118 8, , , 36 36 6%) %) %), , no no non-n-n cardiothoracic surgery (n=69, 21%), acute myocardial infarction (n=56, 17%), acute infection n n=5 =5 =54, 4, 4, 1 1 17% 7% 7%) ), ), and nd d o o oth t er (n=28, 9%). The crude p p pro ro r p p portions of AF F r recur ur rre re renc n e ranged from 47-significantly reduced risk of incident heart failure among individuals with a secondary AF In addition to the 1409 individuals included in our analysis, 121 (7.9%) presented with atrial flutter as their initial rhythm (Supplemental Table 3 ), of which 51 (42%) occurred in the setting of a secondary precipitant. In a sensitivity analysis we included participants with atrial flutter and tested the associations between secondary AF precipitants and clinical outcomes (Supplemental Table 4 ). The observed associations between secondary AF precipitants and AF or flutter recurrence, heart failure, stroke, and mortality did not differ substantively from those in the sample of participants with AF alone.
Discussion
In our community-based study, about one-third of all incident AF cases were associated with a secondary, or potentially reversible, AF precipitant. The most common secondary precipitants were surgery, acute infection, and myocardial infarction. Though the risk of AF recurrence was greater among individuals without a secondary precipitant, nearly two-thirds of individuals in whom initial AF was attributed to a secondary precipitant had recurrent AF within 15 years. The associations between secondary precipitants and recurrent AF were robust to adjustment for a number of widely accepted AF risk factors, including valvular heart disease. Despite lower risk for AF recurrence, long-term risks of stroke and mortality were similar between those with and without secondary AF precipitants. The risk of incident heart failure was reduced by about 25%
Supplemental Table 4 ). The observed associations between secondary AF prec cip i ipit it i an n nts ts ts a a and nd nd A AF n or flutter recurrence, heart failure, stroke, and mortality did not differ substantively from those in There has been longstanding recognition that AF may recur after an initial episode, though reported recurrence rates have varied widely. Prior estimates of AF recurrence range from 22%-49% within the first three years of detection, [17] [18] [19] [20] to over 60% at five years of followup. 14 Substantial variability in AF recurrence rates in these and other reports, 14, 15, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] likely reflects heterogeneity in the sample populations, frequency of cardiac rhythm assessments, and durations of follow-up. 28 Our community-based findings are consistent with high long-term risks of AF recurrence previously reported.
Our findings support the high AF recurrence rates associated with specific secondary AF precipitants reported in several studies with shorter follow-up. Some, 29, 30 but not all, [31] [32] [33] series have reported that AF after cardiac surgery is associated with an increased risk of subsequent AF. In a single-center report of 88 individuals with incident AF in the context of non-ST segment elevation myocardial infarction, 38% had recurrent AF at an average of 21 months of follow-up. 34 A recent study using Medicare claims data reported that AF recurred in 55% of individuals with new-onset AF in the context of sepsis at 5 years. 35 In a single-center study of 58 individuals with thyrotoxicosis-associated AF, 59% had recurrent AF at an average of 24 months of follow-up, 36 whereas a separate retrospective series of 106 patients reported that 38% had from 22%-49% within the first three years of detection, [17] [18] [19] [20] to over 60% at five y y yea ears r r o of f f fo fo foll ll llow ow oup. 14 Substantial variability in AF recurrence rates in these and other reports, 14, 15, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] likely e efl fl lec e ects ts ts h h het et eter e e o o ogen en ne ei eity t in the sample populations s, , f fre e equency of car r rdi d d ac c r r rhy hy hythm assessments, and d du dura a rati t ons of f fol ol llo lo low w w-up up p. 28 28 8 O O Our ur ur c c com om mm mu mun n nit ty y-ba a ase ed f fin ind ding ng ngs s s ar ar re c con on nsi ist sten ent t w wi with th h h h hig igh h h lo lo ong ng n -t -er er erm m ri i is sks of f f A A AF F F re re r cu cu urr rr rre en ence ce e p p pre rev v v o ious usly ly r r rep ep por or orte te ted. d
Our fi find nd ndin in ngs gs gs s sup up uppo po ort rt r t t the he e h h hig ig gh h h AF AF AF r r rec ec ecur ur u re re r nc nc nce e e ra r te te es s s as as asso so soci ci ciat a a ed ed ed w w wit it ith h h sp sp spec ec cif if fic ic ic s s sec ec econdary AF F recurrent AF at almost seven years of follow-up. 37 Similarly, substantial rates of AF recurrence were observed in association with new-onset AF attributed to alcohol consumption, irrespective of alcohol abuse during follow-up. 38 Our study has three major implications. First, our data suggest that AF occurring in acute care settings is an indicator of increased future AF risk. Indeed, we observed that recurrent AF was frequent across common secondary precipitant subgroups, despite a lower average risk of AF recurrence among individuals with a secondary precipitant as compared to those without.
These findings support aforementioned studies of secondary AF precipitants, 29, 30, [33] [34] [35] [36] [37] [38] and imply that increased vigilance for recurrent AF may be warranted in patients with a first-detected AF episode associated with a secondary AF precipitant. Reversing an acute AF precipitant may not dependably protect against long-term AF recurrence.
Second, our observations suggest that AF episodes, irrespective of the precipitant, often serve as markers of elevated risk for long-term stroke and mortality. Prior reports have indicated that new-onset AF occurring with myocardial infarction, 39 sepsis, 40 or cardiac surgery 41, 42 are associated with increased morbidity relative to individuals without AF in these settings. Our findings extend these observations by demonstrating that long-term risks of stroke and mortality in individuals with new-onset AF were similar regardless of the AF precipitant, though we did observe a lower risk of heart failure in those with a secondary AF precipitant. The fact that stroke and mortality occurred with a similar incidence despite a slightly lower risk of recurrent AF in individuals with secondary precipitants may be explained by potential underestimation of recurrent AF in the secondary AF group, differences in specific preventive therapies, lack of causality between AF and the clinical event, or lack of causality between the secondary precipitant and AF.
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Evidence-based guidelines are lacking with respect to the management of patients with AF occurring in the context of secondary precipitants. For example, the American College of Chest Physicians proposes discontinuation of anticoagulation after 30 days of sinus rhythm in patients with postoperative AF following cardiac surgery if AF is felt unlikely to recur, though no metrics are proposed to determine the likelihood of AF persistence or recurrence in this population. 45 In aggregate, our findings imply that AF occurring in the context of a secondary precipitant should not be dismissed, and that increased vigilance is warranted given the likelihood of AF recurrence.
Presently, the optimal surveillance and thromboembolism prophylaxis strategies in patients with secondary AF remain unclear. While existing and future health technologies such as cardiac rhythm monitoring devices may ultimately be resource effective for AF detection and prevention of AF-related morbidity, we advocate for prospective examination of such strategies. In the meantime, we submit that it is reasonable for patients to be educated regarding potential signs of ndividuals with AF in the context of secondary precipitants and those without.
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We fit several multivariable models adjusting for a range of well-established risk factors for each clinical outcome, given the potential multifactorial etiology of AF as well as each outcome.
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We had limited precision to assess for differences in risks of AF recurrence between specific secondary AF precipitants. However, in unadjusted analyses, AF recurrence appeared frequent across common secondary precipitant subgroups despite evidence suggesting heterogeneity in recurrence rates. Although we studied AF-related morbidity, we recognize that clinical events occurring after first-detected AF may not have been causally related to AF.
Residual confounding may obscure associations between secondary precipitants and morbidity.
We acknowledge that some potentially reversible precipitants were not represented in our analysis, including AF occurring in the context of electrolyte abnormalities, exposure to other medications, or other factors. It is not uncommon for older adults to have comorbidities, and it may be difficult to distinguish the etiology of AF in setting of multiple comorbidities. The sample is comprised of middle-age to older adults predominantly of European ancestry, and therefore may not be generalizable to younger individuals or those of other racial and ethnic groups. Nevertheless the age distribution of individuals with AF in our sample is representative of AF occurring in the United States population. 49, 50 In conclusion, in our community-based sample of individuals with first-detected AF, most had recurrent AF at some point later in life. Nearly two-thirds of individuals with a seemingly reversible precipitant associated with a first-detected AF episode had recurrence of the arrhythmia. Individuals with AF associated with a potentially reversible cause had a lower risk of heart failure but similar risks of stroke and mortality over follow-up as compared to individuals without such precipitants. Increased vigilance appears warranted in patients with AF occurring in
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SUPPLEMENTAL METHODS
Assessment of covariates
Diabetes was diagnosed if the Framingham Heart Study fasting glucose was ≥126 mg/dL, nonfasting blood glucose ≥200 mg/dL, or if a participant was using hypoglycemic medications. A clinically significant cardiac murmur was used as a surrogate for valvular heart disease, and was diagnosed in the presence of a systolic murmur that was at least grade three of six in intensity, or if any diastolic murmur was auscultated by a Framingham Heart Study clinic physician. Framingham Heart Study physicians measured blood pressure twice in the seated position. Current smoking was defined as the self-reported regular use of cigarettes in the year preceding the examination.
Ascertainment of myocardial infarction, stroke, incident heart failure, and death All events were adjudicated by a panel of three Framingham Heart Study investigators using previously published written criteria. A history of myocardial infarction was diagnosed if it occurred on the basis of diagnostic ST elevation on an electrocardiogram, or a compatible rise in cardiac enzymes and consistent history. Ascertainment of incident stroke events in the Framingham Heart Study has been previously described. 1 Briefly, stroke is defined as the acute onset of a focal neurological deficit of presumed or definite vascular pathogenesis lasting for greater than 24 hours. Data from imaging, laboratory, noninvasive vascular, and cardiac studies, as well as autopsy examinations, were used for ascertainment when available. Heart failure events were ascertained on the basis of two major or one major and two minor clinical criteria. 2 Major criteria included paroxysmal nocturnal dyspnea or orthopnea, rales on auscultation, third heart sound, radiographic pulmonary edema, distended neck veins, increased venous pressure, hepatojugular reflux, significant weight loss on diuretic therapy, and increasing radiographic cardiomegaly. Minor criteria were comprised of night cough, ankle edema, dyspnea on exertion, pleural effusion, hepatomegaly, radiographic pulmonary vascular redistribution, tachycardia, and decrease in vital capacity.
Ascertainment of atrial flutter (for sensitivity analyses)
Participants were diagnosed with atrial flutter if the arrhythmia was present on an electrocardiogram obtained at a Framingham Heart Study clinic visit or encounter with an external clinician, Holter monitoring, or noted in hospital records as previously described.
3,4 A panel of five clinicians resolved disagreements between adjudications of fibrillation and flutter after reviewing the electrocardiograms. 0.74 HR = hazard ratio; CI = confidence interval *Age at initial atrial fibrillation or flutter, sex, cohort, year of first-detected atrial fibrillation or flutter, current smoking status, height, weight, hypertension treatment, systolic blood pressure, diastolic blood pressure, diabetes, valvular heart disease, prevalent myocardial infarction, and prevalent heart failure (in analyses of stroke and death).
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